Interest-Based Ads

Advertising Cookies: We would like to set third-party advertising cookies on your browser for this health-related website to help us serve relevant health-related advertisements to you about our products or services when you visit other websites. For more information, visit our Privacy Policy. Do you want to set these advertising cookies on this browser?

Prescribing Info, Including Patient Info
Novartis Patient Support 866-433-8000 Mon-Fri 8:00am-8:00pm ET, excluding holidays

Home
- About SCEMBLIX
- Side Effects
  - Understanding SCEMBLIX Side Effects
- Patient Support
- About Ph+ CML-CP

Patients HCP

This site is for US residents only.

Prescribing Info Including Patient Info

Site Map

Home
About SCEMBLIX
- Starting on SCEMBLIX
- Switching to SCEMBLIX
- How to Take SCEMBLIX
- SCEMBLIX for T315I Mutation
Side Effects
- Understanding SCEMBLIX Side Effects
Patient Support
- Savings & Support
- Sign Up to Learn More
- Helpful Resources
About Ph+ CML-CP
- Understanding Ph+ CML in Chronic Phase
- Treatment Milestones
- Monitoring Ph+ CML in Chronic Phase
- Glossary

Important Safety Information

Before taking SCEMBLIX, tell your doctor about all your medical conditions, including if you:

have a history of inflammation of your pancreas (pancreatitis)
have a history of heart problems or blood clots in your arteries and veins (types of blood vessels)
are pregnant or plan to become pregnant. SCEMBLIX can harm your unborn baby ...

Approved Uses

SCEMBLIX is a prescription medicine used to treat adults with:

Philadelphia chromosome–positive chronic myeloid leukemia (Ph+ CML) in chronic phase (CP), previously treated with 2 or more tyrosine kinase inhibitors (TKIs)
Ph+ CML in CP with the T315I mutation ...

Click or scroll to see IMPORTANT SAFETY INFORMATION AND APPROVED USES